Go Pro

Trinseo (TSE) Competitors

Trinseo logo
$0.23 0.00 (0.00%)
As of 09/17/2026

TSE vs. ENFY, SSL, CC, BLGO, and BIOX

Should you buy Trinseo stock or one of its competitors? Trinseo's main competitors and comparable companies include Enlightify (ENFY), Sasol (SSL), Chemours (CC), BioLargo (BLGO), and Bioceres Crop Solutions (BIOX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "chemicals" industry.

How does Trinseo compare to Enlightify?

Enlightify (NYSE:ENFY) and Trinseo (NYSE:TSE) are both small-cap materials companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, earnings, media sentiment, dividends, profitability, risk and institutional ownership.

Enlightify has a beta of -4.61, meaning that its share price is 561% less volatile than the broader market. Comparatively, Trinseo has a beta of 1.46, meaning that its share price is 46% more volatile than the broader market.

Trinseo has a net margin of -13.15% compared to Enlightify's net margin of -22.98%. Trinseo's return on equity of 0.00% beat Enlightify's return on equity.

Company Net Margins Return on Equity Return on Assets
Enlightify-22.98% -18.78% -11.03%
Trinseo -13.15%N/A -11.72%

In the previous week, Enlightify's average media sentiment score of 0.00 equaled Trinseo'saverage media sentiment score.

Company Overall Sentiment
Enlightify Neutral
Trinseo Neutral

Trinseo has a consensus target price of $1.00, indicating a potential upside of 334.78%. Given Trinseo's stronger consensus rating and higher possible upside, analysts clearly believe Trinseo is more favorable than Enlightify.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Enlightify
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Trinseo
1 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67

Enlightify has higher earnings, but lower revenue than Trinseo. Trinseo is trading at a lower price-to-earnings ratio than Enlightify, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Enlightify$79.21M0.00-$28.41M-$0.86N/A
Trinseo$3.13B0.00-$348.50M-$11.55N/A

0.1% of Enlightify shares are owned by institutional investors. Comparatively, 82.7% of Trinseo shares are owned by institutional investors. 14.2% of Enlightify shares are owned by company insiders. Comparatively, 4.5% of Trinseo shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Trinseo beats Enlightify on 8 of the 13 factors compared between the two stocks.

How does Trinseo compare to Sasol?

Sasol (NYSE:SSL) and Trinseo (NYSE:TSE) are both materials companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, valuation, dividends, media sentiment, profitability, earnings and institutional ownership.

In the previous week, Sasol had 8 more articles in the media than Trinseo. MarketBeat recorded 8 mentions for Sasol and 0 mentions for Trinseo. Sasol's average media sentiment score of 0.30 beat Trinseo's score of 0.00 indicating that Sasol is being referred to more favorably in the media.

Company Overall Sentiment
Sasol Neutral
Trinseo Neutral

Sasol has a net margin of 0.00% compared to Trinseo's net margin of -13.15%.

Company Net Margins Return on Equity Return on Assets
SasolN/A N/A N/A
Trinseo -13.15%N/A -11.72%

Sasol has higher revenue and earnings than Trinseo.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sasol$272.12B0.03$719.22MN/AN/A
Trinseo$3.13B0.00-$348.50M-$11.55N/A

Sasol has a beta of 0.01, indicating that its share price is 99% less volatile than the broader market. Comparatively, Trinseo has a beta of 1.46, indicating that its share price is 46% more volatile than the broader market.

Trinseo has a consensus price target of $1.00, indicating a potential upside of 334.78%. Given Trinseo's higher possible upside, analysts clearly believe Trinseo is more favorable than Sasol.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sasol
1 Sell rating(s)
5 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.13
Trinseo
1 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67

Sasol pays an annual dividend of $0.08 per share and has a dividend yield of 0.6%. Trinseo pays an annual dividend of $0.04 per share and has a dividend yield of 17.4%. Trinseo pays out -0.3% of its earnings in the form of a dividend. Trinseo has raised its dividend for 1 consecutive years. Trinseo is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

1.2% of Sasol shares are owned by institutional investors. Comparatively, 82.7% of Trinseo shares are owned by institutional investors. 1.0% of Sasol shares are owned by insiders. Comparatively, 4.5% of Trinseo shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Sasol beats Trinseo on 9 of the 16 factors compared between the two stocks.

How does Trinseo compare to Chemours?

Chemours (NYSE:CC) and Trinseo (NYSE:TSE) are both materials companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, dividends, profitability, valuation, earnings, risk and institutional ownership.

Chemours has a beta of 1.42, suggesting that its share price is 42% more volatile than the broader market. Comparatively, Trinseo has a beta of 1.46, suggesting that its share price is 46% more volatile than the broader market.

Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 2.4%. Trinseo pays an annual dividend of $0.04 per share and has a dividend yield of 17.4%. Chemours pays out -18.3% of its earnings in the form of a dividend. Trinseo pays out -0.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Trinseo has raised its dividend for 1 consecutive years. Trinseo is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

In the previous week, Chemours had 7 more articles in the media than Trinseo. MarketBeat recorded 7 mentions for Chemours and 0 mentions for Trinseo. Chemours' average media sentiment score of 0.33 beat Trinseo's score of 0.00 indicating that Chemours is being referred to more favorably in the media.

Company Overall Sentiment
Chemours Neutral
Trinseo Neutral

Chemours has a net margin of -5.00% compared to Trinseo's net margin of -13.15%. Chemours' return on equity of 60.64% beat Trinseo's return on equity.

Company Net Margins Return on Equity Return on Assets
Chemours-5.00% 60.64% 1.48%
Trinseo -13.15%N/A -11.72%

Trinseo has lower revenue, but higher earnings than Chemours. Chemours is trading at a lower price-to-earnings ratio than Trinseo, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Chemours$5.81B0.37-$386M-$1.91N/A
Trinseo$3.13B0.00-$348.50M-$11.55N/A

Chemours presently has a consensus price target of $20.10, indicating a potential upside of 40.49%. Trinseo has a consensus price target of $1.00, indicating a potential upside of 334.78%. Given Trinseo's higher possible upside, analysts clearly believe Trinseo is more favorable than Chemours.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Chemours
1 Sell rating(s)
6 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.33
Trinseo
1 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67

76.3% of Chemours shares are owned by institutional investors. Comparatively, 82.7% of Trinseo shares are owned by institutional investors. 0.9% of Chemours shares are owned by company insiders. Comparatively, 4.5% of Trinseo shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Chemours beats Trinseo on 11 of the 19 factors compared between the two stocks.

How does Trinseo compare to BioLargo?

BioLargo (NASDAQ:BLGO) and Trinseo (NYSE:TSE) are both small-cap materials companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, profitability, dividends, valuation, analyst recommendations, earnings and media sentiment.

Trinseo has a consensus target price of $1.00, indicating a potential upside of 334.78%. Given Trinseo's stronger consensus rating and higher probable upside, analysts clearly believe Trinseo is more favorable than BioLargo.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BioLargo
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Trinseo
1 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67

BioLargo has a beta of -0.13, meaning that its share price is 113% less volatile than the broader market. Comparatively, Trinseo has a beta of 1.46, meaning that its share price is 46% more volatile than the broader market.

In the previous week, BioLargo's average media sentiment score of 0.39 beat Trinseo's score of 0.00 indicating that BioLargo is being referred to more favorably in the media.

Company Overall Sentiment
BioLargo Neutral
Trinseo Neutral

BioLargo has higher earnings, but lower revenue than Trinseo. BioLargo is trading at a lower price-to-earnings ratio than Trinseo, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioLargo$12.23M2.47-$3.50M-$0.05N/A
Trinseo$3.13B0.00-$348.50M-$11.55N/A

BioLargo has a net margin of -11.45% compared to Trinseo's net margin of -13.15%. Trinseo's return on equity of 0.00% beat BioLargo's return on equity.

Company Net Margins Return on Equity Return on Assets
BioLargo-11.45% -39.90% -22.06%
Trinseo -13.15%N/A -11.72%

0.0% of BioLargo shares are owned by institutional investors. Comparatively, 82.7% of Trinseo shares are owned by institutional investors. 19.3% of BioLargo shares are owned by insiders. Comparatively, 4.5% of Trinseo shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Trinseo beats BioLargo on 8 of the 14 factors compared between the two stocks.

How does Trinseo compare to Bioceres Crop Solutions?

Trinseo (NYSE:TSE) and Bioceres Crop Solutions (NASDAQ:BIOX) are both small-cap materials companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, institutional ownership, valuation, risk, analyst recommendations, media sentiment, earnings and profitability.

82.7% of Trinseo shares are held by institutional investors. Comparatively, 17.7% of Bioceres Crop Solutions shares are held by institutional investors. 4.5% of Trinseo shares are held by company insiders. Comparatively, 2.3% of Bioceres Crop Solutions shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Bioceres Crop Solutions has lower revenue, but higher earnings than Trinseo. Bioceres Crop Solutions is trading at a lower price-to-earnings ratio than Trinseo, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Trinseo$3.13B0.00-$348.50M-$11.55N/A
Bioceres Crop Solutions$238.30M0.10-$55.42M-$3.66N/A

In the previous week, Bioceres Crop Solutions had 4 more articles in the media than Trinseo. MarketBeat recorded 4 mentions for Bioceres Crop Solutions and 0 mentions for Trinseo. Bioceres Crop Solutions' average media sentiment score of 0.29 beat Trinseo's score of 0.00 indicating that Bioceres Crop Solutions is being referred to more favorably in the news media.

Company Overall Sentiment
Trinseo Neutral
Bioceres Crop Solutions Neutral

Trinseo has a net margin of -13.15% compared to Bioceres Crop Solutions' net margin of -94.76%. Trinseo's return on equity of 0.00% beat Bioceres Crop Solutions' return on equity.

Company Net Margins Return on Equity Return on Assets
Trinseo-13.15% N/A -11.72%
Bioceres Crop Solutions -94.76%-33.17%-8.92%

Trinseo currently has a consensus price target of $1.00, suggesting a potential upside of 334.78%. Bioceres Crop Solutions has a consensus price target of $2.00, suggesting a potential upside of 455.09%. Given Bioceres Crop Solutions' higher probable upside, analysts plainly believe Bioceres Crop Solutions is more favorable than Trinseo.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Trinseo
1 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67
Bioceres Crop Solutions
1 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67

Trinseo has a beta of 1.46, suggesting that its share price is 46% more volatile than the broader market. Comparatively, Bioceres Crop Solutions has a beta of 0.44, suggesting that its share price is 56% less volatile than the broader market.

Summary

Trinseo and Bioceres Crop Solutions tied by winning 7 of the 14 factors compared between the two stocks.

Get Trinseo News Delivered to You Automatically

Sign up to receive the latest news and ratings for TSE and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TSE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TSE vs. The Competition

MetricTrinseoChemicals IndustryMaterials SectorNYSE Exchange
Market Cap$8.10M$11.09B$4.85B$22.96B
Dividend YieldN/A2.88%4.70%3.59%
P/E Ratio-0.0237.2425.7228.22
Price / Sales0.0055.0016,889.1586.56
Price / CashN/A14.9226.6533.29
Price / Book-0.013.2010.084.67
Net Income-$348.50M$222.40M$158.15M$1.07B
7 Day PerformanceN/A-1.16%-0.74%-1.65%
1 Month PerformanceN/A-1.59%0.98%-3.58%
1 Year Performance-91.19%16.47%29.08%7.58%

Trinseo Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TSE
Trinseo
1.2414 of 5 stars
$0.23
flat
$1.00
+334.8%
N/A$8.10M$3.13BN/A2,950
ENFY
Enlightify
N/A$0.00
flat
N/A-100.0%$8K$79.21MN/A424
SSL
Sasol
2.228 of 5 stars
$13.13
+7.0%
N/A+108.5%$8.53B$16.12BN/A27,411
CC
Chemours
4.4357 of 5 stars
$15.35
+0.3%
$20.10
+31.0%
-15.9%$2.31B$5.81BN/A5,700
BLGO
BioLargo
N/A$0.09
+2.7%
N/A-56.4%$29.68M$12.23MN/A30

Related Companies and Tools


This page (NYSE:TSE) was last updated on 9/18/2026 by MarketBeat.com Staff.
From Our Partners